Trial intelligence / Profile preview

Marcaine for post-operative pain in breast reduction surgery

NCT04494880Phase 1Completed

Sponsor
Upstate Medical University
Start
Dec 2020
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Upstate Medical University. Primary endpoint: Post-Operative Pain Scale Assessment at 1 year. Started Dec 2020; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04494880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04494880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call